Wilson disease

被引:58
作者
El-Youssef, M
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol & Internal Med, Rochester, MN USA
[2] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA
关键词
D O I
10.4065/78.9.1126
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Wilson disease is a rare disorder of copper metabolism that results in accumulation of copper in the liver and subsequently in other organs, mainly the central nervous system and the kidneys. Advances in the diagnosis and treatment of Wilson disease are discussed, with the emphasis that this is a disease of children, adolescents, and young adults. The myriad manifestations of Wilson disease make its diagnosis dependent on a high index of suspicion, and determination of its genetic background is helping to elucidate the genotype-phehotype correlation and the diversity of presentations. Treatment of Wilson disease has progressed from chelation therapy using D-penicillamine and trientine to the more recent use of zinc and finally to the establishment, of liver transplantation as an urgent but excellent modality for fulminant presentation. The evolution of Wilson disease, from a uniformly fatal disease to an eminently treatable disease during the past century is an example of the remarkable advances of modern medicine.
引用
收藏
页码:1126 / 1136
页数:11
相关论文
共 62 条
[1]   Presence of ATP-dependent copper transport in the hepatocyte canalicular membrane of the Long-Evans Cinnamon rat, an animal model of Wilson disease [J].
Adachi, Y ;
Okuyama, Y ;
Miya, H ;
Kamisako, T .
JOURNAL OF HEPATOLOGY, 1997, 26 (01) :216-217
[2]   RENAL FUNCTION IN WILSONS DISEASE [J].
BEARN, AG ;
YU, TF ;
GUTMAN, AB .
JOURNAL OF CLINICAL INVESTIGATION, 1957, 36 (07) :1107-1114
[3]   LIVER-TRANSPLANTATION FOR WILSONS-DISEASE [J].
BELLARY, S ;
HASSANEIN, T ;
VANTHIEL, DH .
JOURNAL OF HEPATOLOGY, 1995, 23 (04) :373-381
[4]  
BOWCOCK AM, 1987, AM J HUM GENET, V41, P27
[5]   Treatment of Wilson's disease with zinc [J].
Brewer, GJ .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (03) :322-324
[6]   TREATMENT OF WILSONS-DISEASE WITH ZINC-XII - DOSE REGIMEN REQUIREMENTS [J].
BREWER, GJ ;
YUZBASIYANGURKAN, V ;
JOHNSON, V ;
DICK, RD ;
WANG, YX .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1993, 305 (04) :199-202
[7]   WILSON DISEASE [J].
BREWER, GJ ;
YUZBASIYANGURKAN, V .
MEDICINE, 1992, 71 (03) :139-164
[8]   ORAL ZINC THERAPY FOR WILSONS-DISEASE [J].
BREWER, GJ ;
HILL, GM ;
PRASAD, AS ;
COSSACK, ZT ;
RABBANI, P .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (03) :314-320
[9]   Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin [J].
Cauza, E ;
MaierDobersberger, T ;
Polli, C ;
Kaserer, K ;
Kramer, L ;
Ferenci, P .
JOURNAL OF HEPATOLOGY, 1997, 27 (02) :358-362
[10]   Western blot analysis in patients with hypocaeruloplasminaemia [J].
Chowrimootoo, GFE ;
Andoh, J ;
Seymour, CA .
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1997, 90 (03) :197-202